Published in Eur J Cancer on October 01, 1998
The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care (Engl) (2001) 1.52
Risk of the "androgen deprivation syndrome" in men receiving androgen deprivation for prostate cancer. Arch Intern Med (2006) 1.38
Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Support Care Cancer (2009) 1.28
Fatigue in patients receiving maintenance dialysis: a review of definitions, measures, and contributing factors. Am J Kidney Dis (2008) 1.18
Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study. BMC Cancer (2006) 1.16
Effect of aerobic exercise and relaxation training on fatigue and physical performance of cancer patients after surgery. A randomised controlled trial. Support Care Cancer (2004) 1.15
Mind-body treatments for the pain-fatigue-sleep disturbance symptom cluster in persons with cancer. J Pain Symptom Manage (2009) 1.12
Effects of endurance training on the physical performance of patients with hematological malignancies during chemotherapy. Support Care Cancer (2003) 1.10
An examination of distress, sleep, and fatigue in metastatic breast cancer patients. Psychooncology (2010) 1.10
Brain metabolomic profiles of lung cancer patients prior to treatment characterized by proton magnetic resonance spectroscopy. Int J Clin Exp Med (2012) 1.07
The influence of resilience on fatigue in cancer patients undergoing radiation therapy (RT). J Cancer Res Clin Oncol (2007) 1.03
Distribution and determinants of patient satisfaction in oncology with a focus on health related quality of life. BMC Health Serv Res (2009) 0.95
Health-related quality of life after robot-assisted distal gastrectomy in early gastric cancer. World J Surg (2014) 0.92
Is cancer-related fatigue more strongly correlated to haematological or to psychological factors in cancer patients? Support Care Cancer (2007) 0.92
Factors associated with cancer-related fatigue in breast cancer patients undergoing endocrine therapy in an urban setting: a cross-sectional study. BMC Cancer (2010) 0.89
Cancer-related fatigue: role of oncology nurses in translating National Comprehensive Cancer Network assessment guidelines into practice. Clin J Oncol Nurs (2008) 0.88
Childhood adversity increases vulnerability for behavioral symptoms and immune dysregulation in women with breast cancer. Brain Behav Immun (2012) 0.86
Prevalence of fatigue among cancer patients receiving various anticancer therapies and its impact on quality of life: a cross-sectional study. Indian J Palliat Care (2012) 0.85
Time course and predictors for cancer-related fatigue in a series of oropharyngeal cancer patients treated with chemoradiation therapy. Oncologist (2012) 0.84
Sleep and fatigue symptoms in children and adolescents with CKD: a cross-sectional analysis from the chronic kidney disease in children (CKiD) study. Am J Kidney Dis (2010) 0.84
Predicting survival in prostate cancer: the role of quality of life assessment. Support Care Cancer (2011) 0.83
Fatigue in advanced cancer patients attending an outpatient palliative radiotherapy clinic as screened by the Edmonton Symptom Assessment System. Support Care Cancer (2011) 0.81
Support group for cancer patients. Does it improve their physical and psychological wellbeing? A pilot study. Support Care Cancer (2005) 0.80
Fatigue--an orphan topic in patients with cancer? Eur J Cancer (1998) 0.79
Fatigue in patients with lung cancer is related with accelerated tryptophan breakdown. PLoS One (2012) 0.79
An examination of cancer-related fatigue through proposed diagnostic criteria in a sample of cancer patients in Taiwan. BMC Cancer (2011) 0.79
Interaction of psychological factors and the effect of epoetin-alfa treatment in cancer patients on hemoglobin and fatigue. Support Care Cancer (2006) 0.78
Reliability of the Brazilian Portuguese version of the fatigue severity scale and its correlation with pulmonary function, dyspnea, and functional capacity in patients with COPD. J Bras Pneumol (2013) 0.78
A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren's Syndrome. PLoS One (2015) 0.77
Randomized study of dexamethasone treatment for delayed emesis, anorexia and fatigue induced by irinotecan. Support Care Cancer (2003) 0.76
Characterizing Fatigue: The Effects of Ethnicity and Acculturation. J Appl Biobehav Res (2012) 0.76
Chronological Changes of Quality of Life in Long-Term Survivors after Gastrectomy for Gastric Cancer. Cancer Res Treat (2016) 0.75
Assessment of Cancer-related Fatigue among Cancer Patients Receiving Various Therapies: A Cross-sectional Observational Study. Indian J Palliat Care (2017) 0.75
Fatigue and its associated psychosocial factors in cancer patients on active palliative treatment measured over time. Support Care Cancer (2015) 0.75
Chronological Changes in Quality of Life after Distal Gastrectomy for Gastric Cancer. J Gastric Cancer (2017) 0.75
[Anemia caused by cancer in the context of palliative care]. Wien Med Wochenschr (2012) 0.75
Could Objective Tests Be Used to Measure Fatigue in Patients with Advanced Cancer? J Pain Symptom Manage (2017) 0.75
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
alpha-Synuclein locus triplication causes Parkinson's disease. Science (2003) 20.20
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
A self-report measure of pubertal status: Reliability, validity, and initial norms. J Youth Adolesc (1988) 12.12
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature (2001) 7.35
A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry (2007) 6.72
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet (2000) 6.12
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science (2001) 6.00
Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med (1998) 5.78
Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature (1996) 5.50
SOR: project methodology. Br J Cancer (2001) 5.24
Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron (1996) 5.14
The emerging tree of West Eurasian mtDNAs: a synthesis of control-region sequences and RFLPs. Am J Hum Genet (1999) 4.80
Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet (1999) 4.17
Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature (1991) 3.86
The life course prospective design: an example of benefits and problems associated with study longevity. Soc Sci Med (2003) 3.84
Nucleotide sequence of the papA gene encoding the Pap pilus subunit of human uropathogenic Escherichia coli. J Bacteriol (1984) 3.73
Prion dementia without characteristic pathology. Lancet (1990) 3.66
Mitochondrial footprints of human expansions in Africa. Am J Hum Genet (1997) 3.42
Routes to diagnosis for cancer - determining the patient journey using multiple routine data sets. Br J Cancer (2012) 3.37
A signal, from human mtDNA, of postglacial recolonization in Europe. Am J Hum Genet (2001) 3.28
Verifying the stroke-free phenotype by structured telephone interview. Stroke (2000) 3.15
Transphenoidal microsurgery of the normal and pathological pituitary. Clin Neurosurg (1969) 3.12
Cloning and sequencing of a Moraxella bovis pilin gene. J Bacteriol (1985) 3.10
The origins of the Polynesians: an interpretation from mitochondrial lineage analysis. Am J Hum Genet (1995) 2.98
Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet (1994) 2.96
Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma. N Engl J Med (1983) 2.88
Do the four clades of the mtDNA haplogroup L2 evolve at different rates? Am J Hum Genet (2001) 2.88
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86
Conducting clinical research in the new NHS: the model of cancer. United Kingdom Coordinating Committee on Cancer Research. BMJ (1994) 2.70
Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J Med Genet (2005) 2.56
Molecular genetic analyses of the Tyrolean Ice Man. Science (1994) 2.53
Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol (2001) 2.50
Susceptibility locus for Alzheimer's disease on chromosome 10. Science (2000) 2.49
Family history and perceived vulnerability to some common diseases: a study of young people and their parents. J Med Genet (1996) 2.49
A full genome scan for late onset Alzheimer's disease. Hum Mol Genet (1999) 2.26
Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet (1998) 2.26
ABC of palliative care. The carers. BMJ (1998) 2.25
alpha-Synuclein shares physical and functional homology with 14-3-3 proteins. J Neurosci (1999) 2.25
A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med (1998) 2.20
Genetic evidence for different male and female roles during cultural transitions in the British Isles. Proc Natl Acad Sci U S A (2001) 2.20
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Assessing patient dependence in Alzheimer's disease. J Gerontol (1994) 2.16
Using a birth cohort to study ageing: representativeness and response rates in the National Survey of Health and Development. Eur J Ageing (2013) 2.12
Cyclin D1 and prognosis in human breast cancer. Int J Cancer (1996) 2.11
alpha-Synuclein gene haplotypes are associated with Parkinson's disease. Hum Mol Genet (2001) 2.07
Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet (2001) 2.01
Restrict genetic susceptibility tests. Nature (1998) 1.99
Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study. Neurology (2001) 1.98
Detecting errors in mtDNA data by phylogenetic analysis. Int J Legal Med (2001) 1.97
Compliance of pediatric and adolescent cancer patients. Cancer (1986) 1.97
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology (2001) 1.95
The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. Hum Mol Genet (2005) 1.94
Glycine 384 is required for presenilin-1 function and is conserved in bacterial polytopic aspartyl proteases. Nat Cell Biol (2000) 1.87
A loss of function mutation of presenilin-2 interferes with amyloid beta-peptide production and notch signaling. J Biol Chem (1999) 1.87
Links between passive smoking and disease: a best-evidence synthesis. A report of the Working Group on Passive Smoking. Clin Invest Med (1990) 1.87
Maintenance chemotherapy for anaplastic small cell carcinoma of the bronchus: a randomised, controlled trial. Cancer Chemother Pharmacol (1986) 1.87
The heritability and genetics of frontotemporal lobar degeneration. Neurology (2009) 1.86
Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p. Acta Neuropathol (2000) 1.79
Hemorrhage, necrosis, and apoplexy in pituitary adenomas. Surg Neurol (1982) 1.79
A predominantly indigenous paternal heritage for the Austronesian-speaking peoples of insular Southeast Asia and Oceania. Am J Hum Genet (2001) 1.76
Alpha-2 macroglobulin gene and Alzheimer disease. Nat Genet (1999) 1.73
Effects of lymphoma on the peripheral nervous system. J R Soc Med (1994) 1.72
Heterogeneity within a large kindred with frontotemporal dementia: a novel progranulin mutation. Neurology (2007) 1.71
Arterial injuries in transsphenoidal surgery for pituitary adenoma; the role of angiography and endovascular treatment. AJNR Am J Neuroradiol (1997) 1.68
Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. III. Neurologic and neuropsychological findings. Arch Gen Psychiatry (1991) 1.67
Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features. Brain (1992) 1.66
A bundle of care to reduce colorectal surgical infections: an Australian experience. J Hosp Infect (2011) 1.65
Widespread alterations of alpha-synuclein in multiple system atrophy. Am J Pathol (1999) 1.65
Stroke, vascular risk factors and depression: Cross-sectional study in a UK Caribbean-born population. Br J Psychiatry (2001) 1.62
mtDNA suggests Polynesian origins in Eastern Indonesia. Am J Hum Genet (1998) 1.62
Healthcare utilization and costs in managed care patients with Alzheimer's disease during the last few years of life. J Am Geriatr Soc (2001) 1.61
Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment. Neurology (1993) 1.60
Multicenter study of predictors of disease course in Alzheimer disease (the "predictors study"). I. Study design, cohort description, and intersite comparisons. Alzheimer Dis Assoc Disord (1993) 1.60
Single-day apolipoprotein E genotyping. J Neurosci Methods (1994) 1.59
Assessment of a DJ-1 (PARK7) polymorphism in Finnish PD. Neurology (2003) 1.59
Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57
Pituitary tumors and the ophthalmologist. Ophthalmology (1983) 1.55
Red cell antibodies detected in antenatal tests on rhesus positive women in South and Mid Wales, 1948-1978. Br J Obstet Gynaecol (1981) 1.55
Median networks: speedy construction and greedy reduction, one simulation, and two case studies from human mtDNA. Mol Phylogenet Evol (2000) 1.52
The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. J Neurosci (2000) 1.51
Extended tracts of homozygosity identify novel candidate genes associated with late-onset Alzheimer's disease. Neurogenetics (2009) 1.50
The Columbia University Scale for Psychopathology in Alzheimer's disease. Arch Neurol (1992) 1.48
Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter. Neurobiol Dis (2001) 1.48
In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression. Mol Ther (2001) 1.47
Release of repressor control of ribonucleotide reductase by thymine starvation. J Biol Chem (1965) 1.46
Genetic studies on chromosome 12 in late-onset Alzheimer disease. JAMA (1998) 1.44
A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. Hum Mol Genet (1999) 1.43
The presenilins and Alzheimer's disease. Hum Mol Genet (1997) 1.43
The mitochondrial gene tree comes of age. Am J Hum Genet (2001) 1.43
Negative feedback regulation of IgE synthesis by murine CD23. Nature (1994) 1.42
Genome-wide association study of Tourette's syndrome. Mol Psychiatry (2012) 1.42
Identification of Native American founder mtDNAs through the analysis of complete mtDNA sequences: some caveats. Ann Hum Genet (2003) 1.41
Lewy bodies in Alzheimer's disease in which the primary lesion is a mutation in the amyloid precursor protein. Neurosci Lett (1994) 1.41
Emergency presentation of cancer and short-term mortality. Br J Cancer (2013) 1.41
[Surgical treatment of pituitary adenoma]. Neurochirurgie (1973) 1.41
Shaving with the aid of static electricity. Ann R Coll Surg Engl (2004) 1.40